Atara Biotherapeutics (ATRA) Insider Trading & Ownership → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Free atra Stock Alerts $0.72 +0.02 (+2.56%) (As of 12:21 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Atara Biotherapeutics (NASDAQ:ATRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.50%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$64,384.40Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$237,993.35 Get ATRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Atara Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ATRA Insider Buying and Selling by Quarter Ad Behind the MarketsThe AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.Here's how you can invest >>> Atara Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/4/2024Anhco NguyenEVPSell10,746$0.72$7,737.12 3/4/2024Pascal TouchonCEOSell24,844$0.72$17,887.68 11/16/2023Anhco NguyenEVPSell8,856$0.39$3,453.84 11/16/2023Eric J HyllengrenCFOSell11,958$0.39$4,663.62 11/16/2023Pascal TouchonCEOSell20,409$0.39$7,959.51 11/13/2023Carol Giltner GallagherDirectorBuy179,020$0.22$39,384.40 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/10/2023William K HeidenDirectorBuy100,000$0.25$25,000.00 8/16/2023Amar MuruganEVPSell8,672$1.65$14,308.80 8/16/2023Eric J HyllengrenCFOSell8,186$1.65$13,506.90 8/16/2023Pascal TouchonCEOSell30,766$1.65$50,763.90 6/27/2023Pascal TouchonCEOSell14,291$1.66$23,723.06 5/16/2023Amar MuruganEVPSell8,389$2.04$17,113.56 5/16/2023Eric J HyllengrenCFOSell7,918$2.04$16,152.72 5/16/2023Pascal TouchonCEOSell29,766$2.04$60,722.64 (Data available from 1/1/2013 forward) ATRA Insider Trading Activity - Frequently Asked Questions Who is on Atara Biotherapeutics's Insider Roster? The list of insiders at Atara Biotherapeutics includes Amar Murugan, Anhco Nguyen, Carol Giltner Gallagher, Eric J Hyllengren, Jakob Dupont, Joe Newell, Kristin Yarema, Matthew K Fust, Pascal Touchon, Utpal Koppikar, and William K Heiden. Learn more on insiders at ATRA. What percentage of Atara Biotherapeutics stock is owned by insiders? 4.50% of Atara Biotherapeutics stock is owned by insiders. Learn more on ATRA's insider holdings. Which Atara Biotherapeutics insiders have been buying company stock? The following insiders have purchased ATRA shares in the last 24 months: Carol Giltner Gallagher ($39,384.40), and William K Heiden ($25,000.00). How much insider buying is happening at Atara Biotherapeutics? Insiders have purchased a total of 279,020 ATRA shares in the last 24 months for a total of $64,384.40 bought. Which Atara Biotherapeutics insiders have been selling company stock? The following insiders have sold ATRA shares in the last 24 months: Amar Murugan ($97,361.73), Anhco Nguyen ($11,190.96), Eric J Hyllengren ($34,323.24), Jakob Dupont ($79,262.28), Pascal Touchon ($538,998.55), and Utpal Koppikar ($126,228.62). How much insider selling is happening at Atara Biotherapeutics? Insiders have sold a total of 318,042 Atara Biotherapeutics shares in the last 24 months for a total of $887,365.38 sold. More Insider Trading Tools from MarketBeat Related Companies: Aligos Therapeutics Insider Transactions Cognition Therapeutics Insider Transactions Ikena Oncology Insider Transactions Turnstone Biologics Insider Transactions Cidara Therapeutics Insider Transactions Passage Bio Insider Transactions Curis Insider Transactions Elutia Insider Transactions AVROBIO Insider Transactions AlloVir Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders Are Buying That Analysts LoveInsider Selling of Amazon Spikes in Q1, but it's Not Time to Sell3 Small Dividend Paying Banks Insiders are Buying3 Stocks Insiders are Buying at New HighsInsider selling at JPM: A Closer Look Amidst Historic CEO Sale This page (NASDAQ:ATRA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atara Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.